Aims and Scope of European Journal of Pharmaceutics and Biopharmaceutics
The European Journal of Pharmaceutics and Biopharmaceutics is a peer-reviewed medical journal and the official journal of the International Association for Pharmaceutical Technology. It publishes research on pharmaceutical technology, pharmaceutical biotechnology, and biopharmaceutics. Less
Key Metrics
CiteScore 

9.7
Eigenfactor 

0.01 - 0.05
Impact Factor 

< 5
SJR 

Q1Biotechnology

SNIP 

1.21
Recommended pre-submission checks
Powered by 

Topics Covered on European Journal of Pharmaceutics and Biopharmaceutics
European Journal of Pharmaceutics and Biopharmaceutics Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in European Journal of Pharmaceutics and Biopharmaceutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in European Journal of Pharmaceutics and Biopharmaceutics
Hyaluronic acid and PEA-based Rutin-loaded nanoparticles as new cardioprotective tool against anthracycline-induced cardiotoxicity.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Safety gaps in pediatric liquid antihypertensive compounding: a scoping review and regulatory-based safety assessment.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Erratum to "'Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein" [Eur. J. Pharm. Biopharm. 226 (2026) 115147
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
A charge-reversible hyaluronic acid prodrug nanoplatform for synergistically enhanced tumor-targeted doxorubicin delivery.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Hyaluronic acid and PEA-based Rutin-loaded nanoparticles as new cardioprotective tool against anthracycline-induced cardiotoxicity.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Safety gaps in pediatric liquid antihypertensive compounding: a scoping review and regulatory-based safety assessment.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Erratum to "'Site-specific enrichment of highly sialylated N-glycans in an erythropoietin-hybrid Fc fusion protein" [Eur. J. Pharm. Biopharm. 226 (2026) 115147
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
A charge-reversible hyaluronic acid prodrug nanoplatform for synergistically enhanced tumor-targeted doxorubicin delivery.
- 1 Sep 2026
- European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V